Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Takeuchi

Showing results (241-250 of 482) with videos related to

Pageof 49
Sort By:
Esophagus : Official Journal of the Japan Esophageal Society|April 8, 2023
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Surgical Endoscopy|March 10, 2026
Stepwise evolution and clinical applicability of negative pressure-based manometric visualization for reliable Veress needle accessMasanori Sato, Kakeru Torii, Yoshihiro Hiramatsu, et al.
Annals of Surgical Oncology|June 12, 2020
Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaAkihiko Okamura, Satoru Matsuda, Shuhei Mayanagi, et al.
World Journal of Gastrointestinal Surgery|February 7, 2022
Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancerMasashi Takeuchi, Hirofumi Kawakubo, Satoru Matsuda, et al.
Annals of Surgical Oncology|June 2, 2023
ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide StudyAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Anticancer Research|August 27, 2011
Phase I study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with resectable advanced gastric cancer (KOGC-01)Tsunehiro Takahashi, Yoshiro Saikawa, Hiromasa Takaishi, et al.
Anticancer Research|September 12, 2013
The neutrophil elastase inhibitor sivelestat suppresses accelerated gastrointestinal tumor growth via peritonitis after cecal ligation and punctureKoshi Kumagai, Yoshiro Saikawa, Hiroya Takeuchi, et al.
Case Reports in Gastroenterology|September 5, 2020
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating FactorYoshifumi Morita, Takanori Sakaguchi, Shinya Ida, et al.
Annals of Surgical Oncology|December 17, 2022
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
BMC Cancer|April 29, 2014
CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinomaTomoyuki Irino, Hiroya Takeuchi, Sachiko Matsuda, et al.
Pageof 49

Showing results (241-250 of 482) with videos related to

Sort By:
Pageof 49
Esophagus : Official Journal of the Japan Esophageal Society|April 8, 2023
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Surgical Endoscopy|March 10, 2026
Stepwise evolution and clinical applicability of negative pressure-based manometric visualization for reliable Veress needle accessMasanori Sato, Kakeru Torii, Yoshihiro Hiramatsu, et al.
Annals of Surgical Oncology|June 12, 2020
Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaAkihiko Okamura, Satoru Matsuda, Shuhei Mayanagi, et al.
World Journal of Gastrointestinal Surgery|February 7, 2022
Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancerMasashi Takeuchi, Hirofumi Kawakubo, Satoru Matsuda, et al.
Annals of Surgical Oncology|June 2, 2023
ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide StudyAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Anticancer Research|August 27, 2011
Phase I study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with resectable advanced gastric cancer (KOGC-01)Tsunehiro Takahashi, Yoshiro Saikawa, Hiromasa Takaishi, et al.
Anticancer Research|September 12, 2013
The neutrophil elastase inhibitor sivelestat suppresses accelerated gastrointestinal tumor growth via peritonitis after cecal ligation and punctureKoshi Kumagai, Yoshiro Saikawa, Hiroya Takeuchi, et al.
Case Reports in Gastroenterology|September 5, 2020
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating FactorYoshifumi Morita, Takanori Sakaguchi, Shinya Ida, et al.
Annals of Surgical Oncology|December 17, 2022
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
BMC Cancer|April 29, 2014
CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinomaTomoyuki Irino, Hiroya Takeuchi, Sachiko Matsuda, et al.
Pageof 49